Drugs / SCX-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03036306 | Jan → Oct 2017 | — | ScarX Corp | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCX-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03036306 ↗ |
| Route | Topical | “topically applied twice a day for 21 days” NCT03036306 ↗ |